The predictive value of DKI in breast cancer: Does tumour subtype affect pathological response evaluations?
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Biomedical Engineering,Biophysics
Reference38 articles.
1. Anti-HER2 CD4+ T-helper type 1 immune response is superior to breast MRI for assessing response to neoadjuvant therapy in patients with HER2-positive breast cancer;De La Cruz;Ann Surg Oncol,2017
2. Alliance for clinical trials in oncology. Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance);Golshan;Ann Surg,2015
3. Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer;Mamounas;Ann Surg Oncol,2015
4. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis;Spring;Clin Cancer Res,2020
5. Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice;Saw;Breast Cancer Res Treat,2019
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The diagnostic value of histogram analysis of DWI and DKI for the mismatch repair status of rectal adenocarcinoma;Heliyon;2024-09
2. Imaging evaluation focused on microstructural tissue changes using tensor-valued diffusion encoding in breast cancers after neoadjuvant chemotherapy: is it a promising way forward?;Gland Surgery;2024-08
3. Comparing extracellular volume fraction with apparent diffusion coefficient for the characterization of breast tumors;European Journal of Radiology;2024-02
4. Amide proton transfer weighted combined with diffusion kurtosis imaging for predicting lymph node metastasis in cervical cancer;Magnetic Resonance Imaging;2024-02
5. Early prediction of pathological response to neoadjuvant chemotherapy of breast tumors: a comparative study using amide proton transfer-weighted, diffusion weighted and dynamic contrast enhanced MRI;Frontiers in Medicine;2024-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3